| January 1, 2005
Saw this DTC ad for Topamax in a recent issue of Newsweek:
I turned the page and found this:
Apparently, they left a lot out of the first page.
< Previous post Previous Post
Next post > Next Post
Define your online reputation. Grow your platform. Be a dynamic speaker.
Comments are moderated before they are published. Please read the comment policy.
unfortuantely consumers succumb to the illusions of promise on the first page, leaving the fine print unread…
Topamax (topiramate) was an anti-epilepsy drug before earning FDA approval for migraine, and like any other AED it has a frightening adverse effect profile. You’ll find a list of many of them here that puts a damper on that happy picture.
Past 6 Months
site by Out:think Group